Alto Neuroscience, Inc.ANRONYSE
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-49.50M
↓ 73% below average
Average (3y)
$-28.62M
Historical baseline
Range
High:$-9.94M
Low:$-49.50M
CAGR
+70.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-49.50M | -45.9% |
| 2023 | $-33.92M | -60.6% |
| 2022 | $-21.13M | -112.5% |
| 2021 | $-9.94M | - |